PortfoliosLab logoPortfoliosLab logo
AJG vs. ABBV
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

AJG vs. ABBV - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Arthur J. Gallagher & Co. (AJG) and AbbVie Inc. (ABBV). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, AJG achieves a -1.36% return, which is significantly lower than ABBV's 13.52% return. Both investments have delivered pretty close results over the past 10 years, with AJG having a 19.74% annualized return and ABBV not far behind at 19.60%.


AJG

1D
-0.09%
1M
18.50%
6M
-1.25%
YTD
-1.36%
1Y
-18.08%
3Y*
6.09%
5Y*
13.67%
10Y*
19.74%
ALL TIME*
12.61%

ABBV

1D
-0.44%
1M
17.87%
6M
20.04%
YTD
13.52%
1Y
38.03%
3Y*
25.04%
5Y*
21.08%
10Y*
19.60%
ALL TIME*
20.49%
*Multi-year figures are annualized to reflect compound growth (CAGR)

AJG vs. ABBV - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
AJG
Arthur J. Gallagher & Co.
-1.36%-8.03%27.34%20.51%12.44%39.02%32.12%31.79%19.19%25.04%
ABBV
AbbVie Inc.
13.52%33.08%18.86%-0.23%24.01%32.43%27.72%1.47%-0.96%60.07%

Correlation

The correlation between AJG and ABBV is 0.13, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.13

Correlation (3Y)
Calculated over the trailing 3-year period

0.24

Correlation (5Y)
Calculated over the trailing 5-year period

0.27

Correlation (10Y)
Calculated over the trailing 10-year period

0.30

Correlation (All Time)
Calculated using the full available price history since Jan 2, 2013

0.32

The correlation between AJG and ABBV shifts across timeframes, from 0.13 (1 year) to 0.32 (all time), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

AJG:

$65.18B

ABBV:

$447.67B

EPS

AJG:

$5.74

ABBV:

$2.05

PE Ratio

AJG:

44.21

ABBV:

123.48

PS Ratio

AJG:

4.74

ABBV:

7.15

Total Revenue (TTM)

AJG:

$13.94B

ABBV:

$62.82B

Gross Profit (TTM)

AJG:

$7.63B

ABBV:

$46.15B

EBITDA (TTM)

AJG:

$3.66B

ABBV:

$17.96B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

AJG vs. ABBV — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

AJG
AJG Risk / Return Rank: 2323
Overall Rank
AJG Sharpe Ratio Rank: 1717
Sharpe Ratio Rank
AJG Sortino Ratio Rank: 1919
Sortino Ratio Rank
AJG Omega Ratio Rank: 1919
Omega Ratio Rank
AJG Calmar Ratio Rank: 2929
Calmar Ratio Rank
AJG Martin Ratio Rank: 3030
Martin Ratio Rank

ABBV
ABBV Risk / Return Rank: 8282
Overall Rank
ABBV Sharpe Ratio Rank: 8585
Sharpe Ratio Rank
ABBV Sortino Ratio Rank: 8383
Sortino Ratio Rank
ABBV Omega Ratio Rank: 8181
Omega Ratio Rank
ABBV Calmar Ratio Rank: 8181
Calmar Ratio Rank
ABBV Martin Ratio Rank: 7979
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

AJG vs. ABBV - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Arthur J. Gallagher & Co. (AJG) and AbbVie Inc. (ABBV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


AJGABBVDifference
Sharpe ratioReturn per unit of total volatility

-2.08

Sortino ratioReturn per unit of downside risk

-2.88

Omega ratioGain probability vs. loss probability

0.91

1.27

-0.36

Calmar ratioReturn relative to maximum drawdown

-0.47

2.21

-2.68

Martin ratioReturn relative to average drawdown

-0.79

4.89

-5.67

AJG vs. ABBV - Sharpe Ratio Comparison

The current AJG Sharpe Ratio is -0.61, which is lower than the ABBV Sharpe Ratio of 1.47. The chart below compares the historical Sharpe Ratios of AJG and ABBV, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

AJG vs. ABBV - Drawdown Comparison

The maximum AJG drawdown since its inception was -57.49%, which is greater than ABBV's maximum drawdown of -45.09%. Use the drawdown chart below to compare losses from any high point for AJG and ABBV.


Loading charts...

Drawdown Indicators


AJGABBVDifference

Max Drawdown

Largest peak-to-trough decline

-57.49%

-45.09%

-12.40%

Max Drawdown (1Y)

Largest decline over 1 year

-38.59%

-17.32%

-21.27%

Max Drawdown (3Y)

Largest decline over 3 years

-44.40%

-20.74%

-23.66%

Max Drawdown (5Y)

Largest decline over 5 years

-44.40%

-21.92%

-22.48%

Max Drawdown (10Y)

Largest decline over 10 years

-44.40%

-45.09%

+0.69%

Current Drawdown

Current decline from peak

-26.31%

-2.25%

-24.06%

Average Drawdown

Average peak-to-trough decline

-12.87%

-10.66%

-2.21%

Ulcer Index

Depth and duration of drawdowns from previous peaks

23.05%

7.80%

+15.25%

Volatility

AJG vs. ABBV - Volatility Comparison

Arthur J. Gallagher & Co. (AJG) and AbbVie Inc. (ABBV) have volatilities of 10.92% and 10.69%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


AJGABBVDifference

Volatility (1M)

Calculated over the trailing 1-month period

10.92%

10.69%

+0.23%

Volatility (6M)

Calculated over the trailing 6-month period

24.11%

19.21%

+4.90%

Volatility (1Y)

Calculated over the trailing 1-year period

29.72%

26.01%

+3.71%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

23.42%

23.39%

+0.03%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

23.24%

25.90%

-2.66%

Dividends

AJG vs. ABBV - Dividend Comparison

AJG's dividend yield for the trailing twelve months is around 1.06%, less than ABBV's 2.70% yield.


PositionTTM20252024202320222021202020192018201720162015
ABBV
AbbVie Inc.
2.70%2.87%3.49%3.82%3.49%3.84%4.41%4.83%3.89%2.65%3.64%3.41%
AJG
Arthur J. Gallagher & Co.
1.06%1.00%0.85%0.98%1.08%1.13%1.46%1.81%2.23%2.47%2.93%3.62%

Financials

AJG vs. ABBV - Financials Comparison

This section allows you to compare key financial metrics between Arthur J. Gallagher & Co. and AbbVie Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.005.00B10.00B15.00BJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober2026
3.63B
15.00B
(AJG) Total Revenue
(ABBV) Total Revenue
Values in USD except per share items

AJG vs. ABBV - Profitability Comparison

The chart below illustrates the profitability comparison between Arthur J. Gallagher & Co. and AbbVie Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

30.0%40.0%50.0%60.0%70.0%80.0%90.0%JulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober2026
39.1%
83.5%
Portfolio components
AJG - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, Arthur J. Gallagher & Co. reported a gross profit of 1.42B and revenue of 3.63B. Therefore, the gross margin over that period was 39.1%.

ABBV - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, AbbVie Inc. reported a gross profit of 12.53B and revenue of 15.00B. Therefore, the gross margin over that period was 83.5%.

AJG - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, Arthur J. Gallagher & Co. reported an operating income of 341.00M and revenue of 3.63B, resulting in an operating margin of 9.4%.

ABBV - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, AbbVie Inc. reported an operating income of 4.73B and revenue of 15.00B, resulting in an operating margin of 31.6%.

AJG - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, Arthur J. Gallagher & Co. reported a net income of 151.00M and revenue of 3.63B, resulting in a net margin of 4.2%.

ABBV - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, AbbVie Inc. reported a net income of 699.00M and revenue of 15.00B, resulting in a net margin of 4.7%.


Frequently Asked Questions


AJG and ABBV have a correlation of 0.13, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

AJG has higher volatility (10.92%) compared to ABBV (10.69%). In terms of maximum drawdown, AJG dropped -57.49% vs ABBV's -45.09%.

ABBV currently has the higher Sharpe Ratio (1.47 vs -0.61), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for AJG and ABBV

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer